尿钠排泄、血压、心血管疾病与死亡率:社区水平前瞻性流行病学队列研究
发现钠摄入与血压仅在最高三分位社区呈正相关,心血管事件关联呈非线性,仅在钠摄入大于5克/日的社区呈正相关,而所有国家主要心血管结局随钾摄入增加而下降。
核心结论
- 钠摄入仅在社区平均摄入大于5克/日时与心血管疾病和卒中相关。
- 在这些社区和国家实施减钠策略可能合适,而非所有社区。
- 所有国家主要心血管结局随钾摄入增加而下降。
研究设计与样本
- 用晨尿估算24小时钠钾排泄作为摄入替代指标。
主要发现
- 中国103个社区中82个(80%)平均钠摄入大于5克/日,其他国家266个社区中224个(84%)平均摄入3-5克/日。
- 所有国家主要心血管结局随钾摄入增加而下降。
临床怎么用
- 在社区平均钠摄入大于5克/日的地区(如中国部分社区)可考虑推行减钠策略。
- 在钠摄入较低社区,减钠策略需谨慎,因最低三分位钠摄入与心血管事件呈负相关。
- 增加钾摄入可能对所有国家心血管结局有益。
局限性
- 用晨尿估算24小时钠钾排泄作为摄入替代指标,可能存在测量误差。
- 社区水平分析,个体水平数据仅用于混杂调整,不能直接推断个体因果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: WHO recommends that populations consume less than 2 g/day sodium as a preventive measure against cardiovascular disease, but this target has not been achieved in any country. This recommendation is primarily based on individual-level data from short-term trials of blood pressure (BP) without data relating low sodium intake to reduced cardiovascular events from randomised trials or observational studies. We investigated the associations between community-level mean sodium and potassium intake, cardiovascular disease, and mortality. METHODS: The Prospective Urban Rural Epidemiology study is ongoing in 21 countries. Here we report an analysis done in 18 countries with data on clinical outcomes. Eligible participants were adults aged 35-70 years without cardiovascular disease, sampled from the general population. We used morning fasting urine to estimate 24 h sodium and potassium excretion as a surrogate for intake. We assessed community-level associations between sodium and potassium intake and BP in 369 communities (all >50 participants) and cardiovascular disease and mortality in 255 communities (all >100 participants), and used individual-level data to adjust for known confounders. FINDINGS: 95 767 participants in 369 communities were assessed for BP and 82 544 in 255 communities for cardiovascular outcomes with follow-up for a median of 8·1 years. 82 (80%) of 103 communities in China had a mean sodium intake greater than 5 g/day, whereas in other countries 224 (84%) of 266 communities had a mean intake of 3-5 g/day. Overall, mean systolic BP increased by 2·86 mm Hg per 1 g increase in mean sodium intake, but positive associations were only seen among the communities in the highest tertile of sodium intake (p<0·0001 for heterogeneity). The association between mean sodium intake and major cardiovascular events showed significant deviations from linearity (p=0·043) due to a significant inverse association in the lowest tertile of sodium intake (lowest tertile <4·43 g/day, mean intake 4·04 g/day, range 3·42-4·43; change -1·00 events per 1000 years, 95% CI -2·00 to -0·01, p=0·0497), no association in the middle tertile (middle tertile 4·43-5·08 g/day, mean intake 4·70 g/day, 4·44-5.05; change 0·24 events per 1000 years, -2·12 to 2·61, p=0·8391), and a positive but non-significant association in the highest tertile (highest tertile >5·08 g/day, mean intake 5·75 g/day, >5·08-7·49; change 0·37 events per 1000 years, -0·03 to 0·78, p=0·0712). A strong association was seen with stroke in China (mean sodium intake 5·58 g/day, 0·42 events per 1000 years, 95% CI 0·16 to 0·67, p=0·0020) compared with in other countries (4·49 g/day, -0·26 events, -0·46 to -0·06, p=0·0124; p<0·0001 for heterogeneity). All major cardiovascular outcomes decreased with increasing potassium intake in all countries. INTERPRETATION: Sodium intake was associated with cardiovascular disease and strokes only in communities where mean intake was greater than 5 g/day. A strategy of sodium reduction in these communities and countries but not in others might be appropriate. FUNDING: Population Health Research Institute, Canadian Institutes of Health Research, Canadian Institutes of Health Canada Strategy for Patient-Oriented Research, Ontario Ministry of Health and Long-Term Care, Heart and Stroke Foundation of Ontario, and European Research Council.
引用
- Mente A, O'Donnell M, Rangarajan S, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018. PMID: 30129465. doi:10.1016/S0140-6736(18)31376-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。